» Articles » PMID: 35629250

A Single Session of Virtual Reality Improved Tiredness, Shortness of Breath, Anxiety, Depression and Well-Being in Hospitalized Individuals with COVID-19: A Randomized Clinical Trial

Abstract

Background: In 2020, the world was surprised by the spread and mass contamination of the new Coronavirus (COVID-19). COVID-19 produces symptoms ranging from a common cold to severe symptoms that can lead to death. Several strategies have been implemented to improve the well-being of patients during their hospitalization, and virtual reality (VR) has been used. However, whether patients hospitalized for COVID-19 can benefit from this intervention remains unclear. Therefore, this study aimed to investigate whether VR contributes to the control of pain symptoms, the sensation of dyspnea, perception of well-being, anxiety, and depression in patients hospitalized with COVID-19.

Methods: A randomized, double-blind clinical trial was designed. Patients underwent a single session of VR and usual care. The experimental group ( = 22) received VR content to promote relaxation, distraction, and stress relief, whereas the control group ( = 22) received non-specific VR content.

Results: The experimental group reported a significant decrease in tiredness, shortness of breath, anxiety, and an increase in the feeling of well-being, whereas the control group showed improvement only in the tiredness and anxiety.

Conclusions: VR is a resource that may improve the symptoms of tiredness, shortness of breath, anxiety, and depression in patients hospitalized with COVID-19. Future studies should investigate the effect of multiple VR sessions on individuals with COVID-19.

Citing Articles

The occurrence mechanism, assessment, and non-pharmacological treatment of dyspnea.

Gao B, Wang S, Jiang S Med Rev (2021). 2024; 4(5):395-412.

PMID: 39444798 PMC: 11495473. DOI: 10.1515/mr-2024-0006.


Immersive Virtual Reality Use in Medical Intensive Care: Mixed Methods Feasibility Study.

Locke B, Tsai T, Mahony Reategui-Rivera C, Gabriel A, Smiley A, Finkelstein J JMIR Serious Games. 2024; 12:e62842.

PMID: 39046869 PMC: 11344185. DOI: 10.2196/62842.


Immersive Technologies for Depression Care: Scoping Review.

Mahony Reategui-Rivera C, Villarreal-Zegarra D, De la Cruz-Torralva K, Diaz-Sanchez P, Finkelstein J JMIR Ment Health. 2024; 11:e56056.

PMID: 38663004 PMC: 11082738. DOI: 10.2196/56056.


Network analysis on psychopathological symptoms, psychological measures, quality of life and COVID-19 related factors in Chinese psychiatric patients in Hong Kong.

Fung V, Chan J, Ching Chui E, Wong C, Chu R, So Y BMC Psychiatry. 2024; 24(1):271.

PMID: 38609962 PMC: 11010282. DOI: 10.1186/s12888-024-05690-7.


Advocating for Action: Exploring the Potential of Virtual Reality in Breathing Exercise - A Review of The Clinical Applications.

Alhammad S Patient Prefer Adherence. 2024; 18:695-707.

PMID: 38524197 PMC: 10960537. DOI: 10.2147/PPA.S451609.


References
1.
Gibbons C . Basics of autonomic nervous system function. Handb Clin Neurol. 2019; 160:407-418. DOI: 10.1016/B978-0-444-64032-1.00027-8. View

2.
Chirico A, Lucidi F, De Laurentiis M, Milanese C, Napoli A, Giordano A . Virtual Reality in Health System: Beyond Entertainment. A Mini-Review on the Efficacy of VR During Cancer Treatment. J Cell Physiol. 2015; 231(2):275-87. DOI: 10.1002/jcp.25117. View

3.
Moser D, Glaus J, Frangou S, Schechter D . Years of life lost due to the psychosocial consequences of COVID-19 mitigation strategies based on Swiss data. Eur Psychiatry. 2020; 63(1):e58. PMC: 7303469. DOI: 10.1192/j.eurpsy.2020.56. View

4.
Lourenco R, Veras R . [Mini-Mental State Examination: psychometric characteristics in elderly outpatients]. Rev Saude Publica. 2006; 40(4):712-9. DOI: 10.1590/s0034-89102006000500023. View

5.
Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View